CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,222 | -92.3% | 20,806 | -89.0% | 0.00% | -89.5% |
Q1 2023 | $3,141,827 | -49.2% | 189,495 | -43.0% | 0.02% | -47.2% |
Q4 2022 | $6,182,900 | -24.9% | 332,414 | -48.2% | 0.04% | -21.7% |
Q3 2022 | $8,234,000 | +231.3% | 641,800 | +81.0% | 0.05% | +206.7% |
Q2 2022 | $2,485,000 | +0.0% | 354,519 | +18.3% | 0.02% | -28.6% |
Q1 2022 | $2,484,000 | +7.3% | 299,595 | -12.3% | 0.02% | -4.5% |
Q4 2021 | $2,314,000 | +288.9% | 341,762 | +204.6% | 0.02% | +214.3% |
Q3 2021 | $595,000 | +72.5% | 112,195 | +86.8% | 0.01% | +75.0% |
Q2 2021 | $345,000 | +148.2% | 60,055 | +99.1% | 0.00% | +100.0% |
Q1 2021 | $139,000 | +32.4% | 30,167 | -3.7% | 0.00% | +100.0% |
Q4 2020 | $105,000 | -11.0% | 31,333 | -20.8% | 0.00% | -50.0% |
Q3 2020 | $118,000 | -35.9% | 39,575 | -0.5% | 0.00% | -33.3% |
Q2 2020 | $184,000 | +80.4% | 39,787 | +46.6% | 0.00% | +50.0% |
Q4 2019 | $102,000 | -67.5% | 27,143 | -66.8% | 0.00% | -66.7% |
Q2 2019 | $314,000 | +912.9% | 81,806 | +537.4% | 0.01% | +200.0% |
Q1 2018 | $31,000 | +40.9% | 12,835 | +11.6% | 0.00% | 0.0% |
Q1 2017 | $22,000 | – | 11,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |